[Announcement] HGPI Endorsed “Joint Statement on the Implementation of Comprehensive Genomic Profiling test” (December 15, 2023)
date : 12/21/2023
Tags: NCDs, Precision Cancer Medicine
On December 15, 2023, Health and Global Policy Institute (HGPI) endorsed “Joint Statement on the Implementation of Comprehensive Genomic Profiling”.
In addition to our Organization, this Joint Statement is endorsed by the Japan Federation of Cancer Patient Groups, the European Federation of Pharmaceutical Industries and Associations (EFPIA Japan), the Pharmaceutical Research and Manufacturers of America (PhRMA), the Japanese Society of Medical Oncology, the Japanese Society of Clinical Oncology, the Japanese Cancer Association, and the Social Insurance Union of Societies Related to Internal Medicine.
This joint statement will be submitted to the Minister of Health, Labour and Welfare, Mr. Keizo Takemi, and other relevant officials.
Currently, the cancer gene panel tests (cancer Comprehensive Genomic Profiling tests) approved for use under the Japanese Health insurance system is only for ” solid tumors for which no standard treatment is available, or with local progression or metastasis for which standard treatment has been terminated (including those for whom termination is expected)”. Under these circumstances, there have been unfortunate cases in which patients have missed treatment opportunities due to deterioration of their general condition, etc., even when a cancer gene panel tests has revealed a gene mutation that can be treated with drug therapy, and it is too late to do so. In order to ensure that patients who need the most appropriate treatment can receive it at the most appropriate time, a number of proposals have been made by related organizations to resolve issues related to insurance reimbursement. We share a strong awareness of these issues and strongly request that the following points in particular be implemented in the FY2024 revision of the medical service fee.
Request
Expand insurance coverage for cancer gene panel testing so that it can be done at the appropriate time from the time of initial treatment.
Please note that the joint statement documents are only available in Japanese.
Top Research & Recommendations Posts
- [Research Report] Building a Mental Health Program for Children and Measuring its Effectiveness (June 16, 2022)
- [Research Report] 2019 Survey on Healthcare in Japan
- [Policy Recommendations] Developing a National Health and Climate Strategy for Japan (June 26, 2024)
- [Announcement] A Turning Point Towards Building Green Healthcare Systems (June 5, 2024)
- [Research Report] The 2023 Public Opinion Survey on Satisfaction in Healthcare in Japan and Healthcare Applications of Generative AI (January 11, 2024)
- [Policy Recommendations] Obesity Control Promotion Project 2023 “The Next Steps for Engaging and Cooperating with Patients, Citizens, and Communities for Implements of Obesity Control Measurements” (April 8, 2024)
- [Policy Recommendations] Kidney Disease Control Promotion Project 2023 “Establishing Kidney Disease Control Measures with Patient, Citizen, and Community Engagement and Collaboration” Policy Recommendations, a Collection of Good Practices of Chronic Kidney Disease (CKD) and Control Measures in Local Governments (February 14, 2024)
- [New Report] Policy Priorities for Super-Ageing Japan: Health Innovation and Economic Growth in the COVID-19 Pandemic Era (February 24, 2021)
- [Report and Recommendations] Discussion Points in Healthcare DX Project Expert Panel Meeting (April 2, 2024)
- [Policy Recommendations] Achieving Equity in Multidisciplinary Pain Treatment and Support Systems for Pain Management (March 31, 2023)
Featured Posts
-
2024-10-07
[Registration Open] Planetary Health Expert Meeting “Building the Future of Healthcare: A Vision for Sustainable and Resilient Health Systems with GGHH” (November 5, 2024)
-
2024-10-28
[Registration Open] (Hybrid Format) Public Symposium “Promoting CVD Control Based on the Needs of People Living with or Affected by Cardiovascular Diseases: Towards Effective Implementation of the Second Phase CVD Control Plans” (November 22, 2024)
-
2024-10-30
[Event Report] Advisory Board Meeting for Meaningful Involvement Promotion Project “Promoting People with Lived Experience Participation in Policy-Making: Building a Social Foundation for Proactive Engagement” (September 11, 2024)
-
2024-10-31
[HGPI Policy Column] (No.49) From the Mental Health Project ”Changes in the Japanese Mental Health Policy and Future Policy Topics” (The 2nd part ”Issues surrounding long-term hospitalization and future policy topics”)